Murayama Takashi, Ogawa Yasuo
Department of Pharmacology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
Am J Physiol Cell Physiol. 2004 Jul;287(1):C36-45. doi: 10.1152/ajpcell.00395.2003. Epub 2004 Feb 25.
We showed that frog alpha-ryanodine receptor (alpha-RyR) had a lower gain of Ca(2+)-induced Ca(2+) release (CICR) activity than beta-RyR in sarcoplasmic reticulum (SR) vesicles, indicating selective "stabilization" of the former isoform (Murayama T and Ogawa Y. J Biol Chem 276: 2953-2960, 2001). To know whether this is also the case with mammalian RyR1, we determined [(3)H]ryanodine binding of RyR1 and RyR3 in bovine diaphragm SR vesicles. The value of [(3)H]ryanodine binding (B) was normalized by the number of maximal binding sites (B(max)), whereby the specific activity of each isoform was expressed. This B/B(max) expression demonstrated that ryanodine binding of individual channels for RyR1 was <15% that for RyR3. Responses to Ca(2+), Mg(2+), adenine nucleotides, and caffeine were not substantially different between in situ and purified isoforms. These results suggest that the gain of CICR activity of RyR1 is markedly lower than that of RyR3 in mammalian skeletal muscle, indicating selective stabilization of RyR1 as is true of frog alpha-RyR. The stabilization was partly eliminated by FK506 and partly by solubilization of the vesicles with CHAPS, each of which was additive to the other. In contrast, high salt, which greatly enhances [(3)H]ryanodine binding, caused only a minor effect on the stabilization of RyR1. None of the T-tubule components, coexisting RyR3, or calmodulin was the cause. The CHAPS-sensitive intra- and intermolecular interactions that are common between mammalian and frog skeletal muscles and the isoform-specific inhibition by FKBP12, which is characteristic of mammals, are likely to be the underlying mechanisms.
我们发现,在肌浆网(SR)囊泡中,青蛙α-兰尼碱受体(α-RyR)的Ca(2+)诱导Ca(2+)释放(CICR)活性增益低于β-RyR,这表明前一种异构体具有选择性“稳定性”(村山T和小川Y。《生物化学杂志》276: 2953 - 2960,2001)。为了了解哺乳动物RyR1是否也是如此,我们测定了牛膈肌SR囊泡中RyR1和RyR3的[(3)H]兰尼碱结合情况。[(3)H]兰尼碱结合值(B)通过最大结合位点数(B(max))进行归一化,从而表示每种异构体的比活性。这种B/B(max)表达表明,RyR1单个通道的兰尼碱结合量不到RyR3的15%。原位异构体和纯化异构体对Ca(2+)、Mg(2+)、腺嘌呤核苷酸和咖啡因的反应没有实质性差异。这些结果表明,在哺乳动物骨骼肌中,RyR1的CICR活性增益明显低于RyR3,这表明RyR1与青蛙α-RyR一样具有选择性稳定性。FK506部分消除了这种稳定性,用CHAPS溶解囊泡也部分消除了这种稳定性,且二者具有相加作用。相比之下,高盐虽然能大大增强[(3)H]兰尼碱结合,但对RyR1的稳定性影响较小。T小管成分、共存的RyR3或钙调蛋白都不是其原因。哺乳动物和青蛙骨骼肌共有的CHAPS敏感的分子内和分子间相互作用,以及哺乳动物特有的FKBP12对异构体的特异性抑制,可能是其潜在机制。